Verano Holdings (VRNO) EBT (2021 - 2026)
Verano Holdings' (VRNO) quarterly EBT came in at -$6.2 million in Q1 2026, down 206.27% year-on-year from $5.8 million in Q1 2025, and up 96.41% on a QoQ basis from -$172.7 million in Q4 2025.
Verano Holdings (VRNO) EBT (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of EBT data on file, last reported at -$6.2 million in Q1 2026.
- On a quarterly basis, EBT fell 206.27% year-over-year to -$6.2 million in Q1 2026; TTM through Mar 2026 was -$178.3 million, a 40.72% increase from a year earlier, with the FY2025 full-year figure at -$166.2 million, up 44.57% from the prior year.
- EBT for Q1 2026 stood at -$6.2 million, up from -$172.7 million in the prior quarter.
- Over the last five years, EBT for VRNO reached as high as $27.0 million in Q3 2023 and fell as low as -$318.2 million in Q4 2024.
- Historically, EBT has averaged -$35.8 million across 5 years, with a median of $5.8 million in 2025.
- Across the five-year window, EBT jumped 1063.85% in 2023 and sank 866.26% in 2024, its largest moves.
- Year by year, EBT stood at -$216.6 million in 2022, then jumped by 84.8% to -$32.9 million in 2023, then sank by 866.26% to -$318.2 million in 2024, then surged by 45.74% to -$172.7 million in 2025, then surged by 96.41% to -$6.2 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$6.2 million in Q1 2026, -$172.7 million in Q4 2025, and -$15.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 437.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 758.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -2.90 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 318.30 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -247.30 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 246.80 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 87.00 Mn |
| 10 | Verano Holdings | 1.99 Bn | 1.92 Bn | 98.98 Mn | -6.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.20 Mn |
| Dec 31, 2025 | -172.68 Mn |
| Sep 30, 2025 | -15.39 Mn |
| Jun 30, 2025 | 16.00 Mn |
| Mar 31, 2025 | 5.83 Mn |
| Dec 31, 2024 | -318.25 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 8.77 Mn |
| Mar 31, 2024 | 6.66 Mn |
| Dec 31, 2023 | -32.94 Mn |
| Sep 30, 2023 | 27.03 Mn |
| Jun 30, 2023 | 14.62 Mn |
| Mar 31, 2023 | 19.08 Mn |
| Dec 31, 2022 | -216.64 Mn |
| Sep 30, 2022 | 26.39 Mn |
| Jun 30, 2022 | 1.26 Mn |
| Mar 31, 2022 | 25.59 Mn |
| Dec 31, 2021 | 30.22 Mn |
| Sep 30, 2021 | 15.12 Mn |
| Jun 30, 2021 | -6.15 Mn |